| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. (AKBA) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. AKBA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.46M | $4.02M | - | |
| CFO | 320.0K | $371.2K | - | |
| Dir | 160.9K | $186.7K | - | |
| Dir | 129.5K | $150.2K | - | |
| VP | 119.0K | $138.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2020 | Gilman Steven C70 | Director | Sell | 4,567 | $12.08 | $55,169.36 | -10.5% | |
| Jun 8, 2020 | Smith Cynthia | Director | Sell | 4,567 | $12.10 | $55,260.70 | -10.8% | |
| Jun 1, 2020 | Faulkingham Dell70 | CCO | Sell | 6,426 | $11.58 | $74,413.08 | -8.0% | |
| Feb 28, 2020 | Amello Jason | SVP, CFO &Treasurer | Sell | 6,976 | $8.70 | $60,691.20 | -4.6% | |
| Feb 28, 2020 | Hadas Nicole R.60 | SVP, Chief Legal Officer | Sell | 7,050 | $8.70 | $61,335.00 | -3.2% | |
| Feb 28, 2020 | Dahan Michel59 | SVP, Chief Operating Officer | Sell | 6,972 | $8.70 | $60,656.40 | -3.3% | |
| Feb 28, 2020 | Tubridy Karen L | SVP, Chief Development Officer | Sell | 3,454 | $8.70 | $30,049.80 | -3.9% | |
| Nov 20, 2019 | Burke Steven Keith61 | SVP, Chief Medical Officer | Buy | 27,000 | $3.58 | $96,660.00 | +270.0% | |
| Nov 20, 2019 | Butler John P.61 | CEO And President | Buy | 50,000 | $3.44 | $172,000.00 | +6.0% | |
| Nov 20, 2019 | Adams Adrian | Director | Buy | 50,000 | $3.41 | $170,500.00 | +365.0% |